nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR1—metabolic syndrome X	0.923	1	CbGaD
Nabilone—Dronabinol—CNR1—metabolic syndrome X	0.00679	1	CrCbGaD
Nabilone—CNR2—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.00663	0.156	CbGpPWpGaD
Nabilone—CNR1—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0052	0.122	CbGpPWpGaD
Nabilone—CNR2—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.00464	0.109	CbGpPWpGaD
Nabilone—Sinus headache—Metformin—metabolic syndrome X	0.00374	0.134	CcSEcCtD
Nabilone—Hypothermia—Metformin—metabolic syndrome X	0.00217	0.078	CcSEcCtD
Nabilone—Body temperature decreased—Metformin—metabolic syndrome X	0.00217	0.078	CcSEcCtD
Nabilone—Lightheadedness—Metformin—metabolic syndrome X	0.00109	0.0391	CcSEcCtD
Nabilone—Nasal congestion—Metformin—metabolic syndrome X	0.00097	0.0348	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.000886	0.0208	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.000823	0.0193	CbGpPWpGaD
Nabilone—Sweating increased—Metformin—metabolic syndrome X	0.000744	0.0267	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000705	0.0166	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.000696	0.0164	CbGpPWpGaD
Nabilone—Drowsiness—Metformin—metabolic syndrome X	0.000681	0.0245	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.000646	0.0152	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000641	0.0151	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.00062	0.0146	CbGpPWpGaD
Nabilone—Hypoaesthesia—Metformin—metabolic syndrome X	0.000609	0.0218	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000575	0.0135	CbGpPWpGaD
Nabilone—Eye disorder—Metformin—metabolic syndrome X	0.000572	0.0205	CcSEcCtD
Nabilone—Flushing—Metformin—metabolic syndrome X	0.000568	0.0204	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000553	0.013	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000549	0.0129	CbGpPWpGaD
Nabilone—Chills—Metformin—metabolic syndrome X	0.000549	0.0197	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000537	0.0126	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000521	0.0122	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000503	0.0118	CbGpPWpGaD
Nabilone—Vision blurred—Metformin—metabolic syndrome X	0.000502	0.018	CcSEcCtD
Nabilone—Tremor—Metformin—metabolic syndrome X	0.000499	0.0179	CcSEcCtD
Nabilone—Ill-defined disorder—Metformin—metabolic syndrome X	0.000494	0.0177	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000493	0.0116	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000481	0.0113	CbGpPWpGaD
Nabilone—Malaise—Metformin—metabolic syndrome X	0.00048	0.0172	CcSEcCtD
Nabilone—Syncope—Metformin—metabolic syndrome X	0.000477	0.0171	CcSEcCtD
Nabilone—Palpitations—Metformin—metabolic syndrome X	0.00047	0.0169	CcSEcCtD
Nabilone—Loss of consciousness—Metformin—metabolic syndrome X	0.000468	0.0168	CcSEcCtD
Nabilone—Hypertension—Metformin—metabolic syndrome X	0.00046	0.0165	CcSEcCtD
Nabilone—Myalgia—Metformin—metabolic syndrome X	0.000453	0.0163	CcSEcCtD
Nabilone—Chest pain—Metformin—metabolic syndrome X	0.000453	0.0163	CcSEcCtD
Nabilone—Discomfort—Metformin—metabolic syndrome X	0.000448	0.0161	CcSEcCtD
Nabilone—Infection—Metformin—metabolic syndrome X	0.000432	0.0155	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000431	0.0101	CbGpPWpGaD
Nabilone—Shock—Metformin—metabolic syndrome X	0.000427	0.0153	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000421	0.00991	CbGpPWpGaD
Nabilone—Hyperhidrosis—Metformin—metabolic syndrome X	0.00042	0.0151	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000418	0.00983	CbGpPWpGaD
Nabilone—Anorexia—Metformin—metabolic syndrome X	0.000414	0.0149	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000408	0.00961	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS1—metabolic syndrome X	0.000408	0.00959	CbGpPWpGaD
Nabilone—Hypotension—Metformin—metabolic syndrome X	0.000406	0.0146	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000402	0.00945	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000396	0.00932	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000396	0.0142	CcSEcCtD
Nabilone—Paraesthesia—Metformin—metabolic syndrome X	0.00039	0.014	CcSEcCtD
Nabilone—Dyspnoea—Metformin—metabolic syndrome X	0.000387	0.0139	CcSEcCtD
Nabilone—Somnolence—Metformin—metabolic syndrome X	0.000386	0.0139	CcSEcCtD
Nabilone—Dyspepsia—Metformin—metabolic syndrome X	0.000382	0.0137	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000382	0.00899	CbGpPWpGaD
Nabilone—Decreased appetite—Metformin—metabolic syndrome X	0.000378	0.0136	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000377	0.00887	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CNR1—metabolic syndrome X	0.000375	0.00883	CbGpPWpGaD
Nabilone—Fatigue—Metformin—metabolic syndrome X	0.000375	0.0135	CcSEcCtD
Nabilone—Constipation—Metformin—metabolic syndrome X	0.000372	0.0133	CcSEcCtD
Nabilone—Feeling abnormal—Metformin—metabolic syndrome X	0.000358	0.0129	CcSEcCtD
Nabilone—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000355	0.0128	CcSEcCtD
Nabilone—Abdominal pain—Metformin—metabolic syndrome X	0.000343	0.0123	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000328	0.00772	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00032	0.00752	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000315	0.00742	CbGpPWpGaD
Nabilone—Asthenia—Metformin—metabolic syndrome X	0.000312	0.0112	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—GHRL—metabolic syndrome X	0.000311	0.00732	CbGpPWpGaD
Nabilone—Pruritus—Metformin—metabolic syndrome X	0.000307	0.011	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000303	0.00713	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.0003	0.00705	CbGpPWpGaD
Nabilone—Diarrhoea—Metformin—metabolic syndrome X	0.000297	0.0107	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000291	0.00684	CbGpPWpGaD
Nabilone—Dizziness—Metformin—metabolic syndrome X	0.000287	0.0103	CcSEcCtD
Nabilone—Vomiting—Metformin—metabolic syndrome X	0.000276	0.00992	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000275	0.00648	CbGpPWpGaD
Nabilone—Rash—Metformin—metabolic syndrome X	0.000274	0.00984	CcSEcCtD
Nabilone—Dermatitis—Metformin—metabolic syndrome X	0.000274	0.00983	CcSEcCtD
Nabilone—Headache—Metformin—metabolic syndrome X	0.000272	0.00977	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000263	0.00619	CbGpPWpGaD
Nabilone—Nausea—Metformin—metabolic syndrome X	0.000258	0.00927	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000251	0.0059	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGT—metabolic syndrome X	0.000243	0.00572	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000238	0.0056	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000236	0.00556	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000228	0.00537	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000224	0.00527	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000216	0.00508	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000215	0.00505	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000212	0.00499	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000207	0.00486	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000203	0.00478	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL2—metabolic syndrome X	0.0002	0.00471	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000193	0.00453	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGT—metabolic syndrome X	0.000191	0.00449	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000185	0.00436	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000182	0.00428	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000176	0.00413	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000168	0.00396	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000164	0.00387	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000163	0.00383	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00016	0.00375	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RBP4—metabolic syndrome X	0.000159	0.00373	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000159	0.00373	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—metabolic syndrome X	0.000157	0.0037	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000157	0.0037	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000149	0.00351	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000149	0.0035	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000143	0.00336	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOC3—metabolic syndrome X	0.00014	0.0033	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000138	0.00323	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000129	0.00303	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000128	0.003	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000127	0.00298	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGT—metabolic syndrome X	0.000125	0.00294	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RBP4—metabolic syndrome X	0.000124	0.00293	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000124	0.00293	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CYBA—metabolic syndrome X	0.000123	0.00289	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GHRL—metabolic syndrome X	0.00012	0.00283	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000117	0.00276	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000117	0.00275	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CNR1—metabolic syndrome X	0.000114	0.00268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOC3—metabolic syndrome X	0.00011	0.00259	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000108	0.00254	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000103	0.00242	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HTR2C—metabolic syndrome X	9.95e-05	0.00234	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGT—metabolic syndrome X	9.8e-05	0.00231	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CYBA—metabolic syndrome X	9.63e-05	0.00227	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GHRL—metabolic syndrome X	9.43e-05	0.00222	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF2—metabolic syndrome X	9.3e-05	0.00219	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOB—metabolic syndrome X	9.03e-05	0.00212	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL5—metabolic syndrome X	8.82e-05	0.00207	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLA2G4A—metabolic syndrome X	8.79e-05	0.00207	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LPL—metabolic syndrome X	8.62e-05	0.00203	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—metabolic syndrome X	8.07e-05	0.0019	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—metabolic syndrome X	7.38e-05	0.00174	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF2—metabolic syndrome X	7.3e-05	0.00172	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOE—metabolic syndrome X	7.23e-05	0.0017	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—metabolic syndrome X	7.23e-05	0.0017	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA1—metabolic syndrome X	7.15e-05	0.00168	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOB—metabolic syndrome X	7.09e-05	0.00167	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL5—metabolic syndrome X	6.92e-05	0.00163	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.89e-05	0.00162	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPL—metabolic syndrome X	6.77e-05	0.00159	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS1—metabolic syndrome X	6.45e-05	0.00152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INS—metabolic syndrome X	6.18e-05	0.00145	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL2—metabolic syndrome X	6.08e-05	0.00143	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—metabolic syndrome X	5.97e-05	0.00141	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—metabolic syndrome X	5.79e-05	0.00136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—metabolic syndrome X	5.67e-05	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—metabolic syndrome X	5.67e-05	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—metabolic syndrome X	5.67e-05	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA1—metabolic syndrome X	5.61e-05	0.00132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—metabolic syndrome X	5.42e-05	0.00127	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS1—metabolic syndrome X	5.06e-05	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INS—metabolic syndrome X	4.85e-05	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—metabolic syndrome X	4.77e-05	0.00112	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—metabolic syndrome X	4.69e-05	0.0011	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—metabolic syndrome X	4.64e-05	0.00109	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—metabolic syndrome X	4.57e-05	0.00107	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—metabolic syndrome X	4.45e-05	0.00105	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—metabolic syndrome X	4.25e-05	0.001	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—metabolic syndrome X	4.21e-05	0.000991	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—metabolic syndrome X	3.64e-05	0.000857	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—metabolic syndrome X	3.58e-05	0.000843	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—metabolic syndrome X	3.58e-05	0.000842	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—metabolic syndrome X	3.31e-05	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—metabolic syndrome X	2.81e-05	0.000661	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—metabolic syndrome X	2.7e-05	0.000635	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—metabolic syndrome X	2.49e-05	0.000586	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—metabolic syndrome X	2.12e-05	0.000498	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—metabolic syndrome X	1.95e-05	0.000459	CbGpPWpGaD
